Skilled lawyers who clients count on to navigate the complexities of the booming Cannabis industry.
Locke Lord was one of the first Am Law 100 firms to create a practice devoted to the cannabis industry. We are industry insiders and have a deep understanding of the myriad of issues that this industry faces. Make no mistake, experienced and knowledgeable lawyers are critical to navigating this industry. This unit is a cross-disciplinary team of skilled lawyers from our regulatory, corporate, finance, tax, real estate, intellectual property, employment, health care, litigation and insurance groups. We work collaboratively to ensure that our clients meet their business goals. Visit our Cannabis Blog for the latest podcasts, news and developments.
Focused On Your Interests
We represent established marijuana companies, cultivation facilities, dispensaries, retailers and a host of other marijuana-related businesses (MRBs) as well as those looking to enter the cannabis market. Our lawyers have extensive experience with licenses (from application and acquisition to variances and litigation), regulators and lobbying at the state and local levels. We also assist clients with labeling, marketing and advertising with respect to cannabis products. We continuously collaborate with clients on the best strategy, never losing sight of their business ambitions.
Navigating Clients Through the Day to Day and Beyond
From cannabis license applicants to multi-state operators, clients turn to our lawyers to help achieve their business goals. We build collaborative relationships in order to create solutions for immediate problems and strategies to address and mitigate future risk.
We assist clients with a wide variety of matters, such as:
Supporting Clients With Extensive Regulatory Knowledge
Our team delivers guidance through the regulatory maze of state-specific agencies for licensing and the advertising, distribution and sale of cannabis and cannabis products. We provide regulatory help regarding cannabis products in the following medical and recreational state markets:
This includes FDA regulatory issues presented by manufacturing, using and selling product solely made of cannabis or its derivatives as well as product that contains cannabis or its derivatives, such as CBD, which are now no longer covered by the Controlled Substances Act under the Farm Bill of 2018. Our lawyers regularly review advertising copy, product packaging materials and labeling requirements to help clients avoid litigation.